1406 related articles for article (PubMed ID: 8689766)
1. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
2. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Sabroe RA; Kennedy CT; Archer CB
Br J Dermatol; 1997 Sep; 137(3):386-90. PubMed ID: 9349334
[TBL] [Abstract][Full Text] [Related]
3. Effects of histamine receptor antagonists on histamine-induced responses in human skin.
Hägermark O; Strandberg K; Grönneberg R
Acta Derm Venereol; 1979; 59(4):297-300. PubMed ID: 92142
[TBL] [Abstract][Full Text] [Related]
4. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
Clough GF; Bennett AR; Church MK
Br J Dermatol; 1998 May; 138(5):806-14. PubMed ID: 9666826
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship between objective measures of histamine-induced weals and dose of terfenadine.
Shall L; Newcombe RG; Lush M; Marks R
Acta Derm Venereol; 1991; 71(3):199-204. PubMed ID: 1678220
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
Van Neste D; Rihoux JP
Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation.
Krause K; Giménez-Arnau A; Martinez-Escala E; Farré-Albadalejo M; Abajian M; Church MK; Maurer M
Allergy; 2013 Feb; 68(2):256-8. PubMed ID: 23320562
[TBL] [Abstract][Full Text] [Related]
8. The intradermal effects of the H3 receptor agonist R alpha methylhistamine in human skin.
Kavanagh GM; Sabroe RA; Greaves MW; Archer CB
Br J Dermatol; 1998 Apr; 138(4):622-6. PubMed ID: 9640366
[TBL] [Abstract][Full Text] [Related]
9. The role of histamine in the acute inflammatory responses to intradermal platelet activating factor.
Sciberras DG; Jordan S; Gill D; Baber NS; James I
Br J Clin Pharmacol; 1991 Jul; 32(1):85-90. PubMed ID: 1679658
[TBL] [Abstract][Full Text] [Related]
10. Effect of H1- and H2-receptor blockade on the inhibition of immediate cutaneous reactions.
Johnson CE; Weiner JS; Wagner DS; McLean JA
Clin Pharm; 1984; 3(1):60-4. PubMed ID: 6141860
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
12. Actions of terfenadine and cimetidine on histamine wheal formation.
Vere DW
Br J Clin Pharmacol; 1995 Dec; 40(6):557-62. PubMed ID: 8703662
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the actions of kallidin and bradykinin in the skin of normal and psoriatic subjects.
Marshman G; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Mar; 21(2):112-5. PubMed ID: 8759196
[TBL] [Abstract][Full Text] [Related]
14. Acrivastine--an evaluation of initial and peak activity in human skin.
Marks P; Manna VK; Gibson JR
J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
[TBL] [Abstract][Full Text] [Related]
15. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists.
Sharif NA; Wiernas TK; Howe WE; Griffin BW; Offord EA; Pfeifer AM
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2562-71. PubMed ID: 9856766
[TBL] [Abstract][Full Text] [Related]
16. Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin.
Fjellner B; Hägermark O
Acta Derm Venereol; 1985; 65(5):409-12. PubMed ID: 2416164
[TBL] [Abstract][Full Text] [Related]
17. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
18. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
19. Use of cetirizine to investigate non-H1 effects of second-generation antihistamines.
Townley RG; Okada C
Ann Allergy; 1992 Feb; 68(2):190-6. PubMed ID: 1346737
[TBL] [Abstract][Full Text] [Related]
20. Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects.
Juhlin L; Pihl-Lundin I
Acta Derm Venereol; 1992; 72(3):197-200. PubMed ID: 1357858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
